Blood component use in critical care in patients with COVID-19 infection: a single-centre experience.


Journal

British journal of haematology
ISSN: 1365-2141
Titre abrégé: Br J Haematol
Pays: England
ID NLM: 0372544

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 13 05 2020
accepted: 25 05 2020
pubmed: 9 7 2020
medline: 1 12 2020
entrez: 9 7 2020
Statut: ppublish

Résumé

There has been a significant surge in admissions to critical care during the coronavirus disease 2019 (COVID-19) pandemic. At present, the demands on blood components have not been described. We reviewed their use during the first 6 weeks of the outbreak from 3 March 2020 in a tertiary-level critical care department providing venovenous extracorporeal membrane oxygenation (vv-ECMO). A total of 265 patients were reviewed, with 235 not requiring ECMO and 30 requiring vv-ECMO. In total, 50 patients required blood components during their critical care admission. Red cell concentrates were the most frequently transfused component in COVID-19-infected patients with higher rates of use during vv-ECMO. The use of fresh frozen plasma, cryoprecipitate and platelet transfusions was low in a period prior to the use of convalescent plasma.

Identifiants

pubmed: 32640484
doi: 10.1111/bjh.17007
pmc: PMC7362152
doi:

Substances chimiques

cryoprecipitate coagulum 0
Factor VIII 9001-27-8
Fibrinogen 9001-32-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

382-385

Informations de copyright

© 2020 British Society for Haematology and John Wiley & Sons Ltd.

Références

Ann Thorac Surg. 2015 Feb;99(2):590-5
pubmed: 25499483
CMAJ. 2020 May 25;192(21):E583
pubmed: 32357997
Intensive Care Med. 2016 Nov;42(11):1715-1722
pubmed: 27686346
N Engl J Med. 2013 Jan 17;368(3):199-201
pubmed: 23323895
Vox Sang. 2020 Aug;115(6):502-506
pubmed: 32347566
Vox Sang. 2003 Apr;84(3):211-8
pubmed: 12670370
Crit Care Explor. 2020 Jan 29;2(1):e0077
pubmed: 32166297
Clin Chim Acta. 2020 Aug;507:174-180
pubmed: 32339487
J Thromb Thrombolysis. 2021 May;51(4):1107-1110
pubmed: 32246317
J Thromb Haemost. 2020 Jul;18(7):1738-1742
pubmed: 32302438
J Racial Ethn Health Disparities. 2020 Jun;7(3):398-402
pubmed: 32306369
Anaesthesia. 2020 Aug;75(8):1105-1113
pubmed: 32339260
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094
N Engl J Med. 1999 Feb 11;340(6):409-17
pubmed: 9971864
Transfusion. 2015 Jan;55(1):91-9
pubmed: 25178387

Auteurs

Andrew J Doyle (AJ)

Department of Clinical Haematology, NHS Foundation Trust, Guy's and St Thomas, London, UK.

Anicee Danaee (A)

Department of Clinical Haematology, NHS Foundation Trust, Guy's and St Thomas, London, UK.

Charlene I Furtado (CI)

Department of Clinical Haematology, NHS Foundation Trust, Guy's and St Thomas, London, UK.

Scott Miller (S)

Department of Clinical Haematology, NHS Foundation Trust, Guy's and St Thomas, London, UK.

Tim Maggs (T)

Viapath Analytics LLP, St Thomas Hospital, London, UK.

Susan E Robinson (SE)

Department of Clinical Haematology, NHS Foundation Trust, Guy's and St Thomas, London, UK.

Andrew Retter (A)

Department of Critical Care, NHS Foundation Trust, Guy's and St Thomas, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH